-
1.
公开(公告)号:US11918728B2
公开(公告)日:2024-03-05
申请号:US17091214
申请日:2020-11-06
发明人: Carol A. Rae , Jan Simoni , Grace Simoni , John F. Moeller , Jose A. Diaz-Aunon
CPC分类号: A61M1/3679 , B01J20/20 , B01J47/02 , A61M5/165 , A61M2202/0021 , A61M2202/0042 , A61M2202/0413 , A61M2202/206
摘要: A method comprising obtaining a bodily fluid from a subject; contacting the bodily fluid with an adsorbent material comprising a synthetic carbon particle (SCP) to produce a first filtrate having a level of disease mediators (y); contacting the first filtrate with an adsorbent material comprising the SCP and an anion exchange resin where the ratio of SCP to anion exchange resin is from about 0.1:100 to 100:0.1 to produce a second filtrate; contacting the second filtrate with an adsorbent material comprising the SCP and a cation exchange resin where the ratio of SCP to cation exchange resin is from about 1:100 to produce a third filtrate; and administering the third filtrate to the subject.
-
公开(公告)号:US20200179548A1
公开(公告)日:2020-06-11
申请号:US16705870
申请日:2019-12-06
发明人: Sharif Anani
摘要: Embodiments relate generally to systems and methods for sterilizing a container comprising a liquid, where a method may comprise placing the container within an autoclave vessel; pressurizing the autoclave vessel to an initial pressure, by pressurizing the autoclave vessel with a clean gas via a first valve; after pressurizing the autoclave vessel to the initial pressure, heating the autoclave vessel to sterilize the liquid within the container within the autoclave vessel; controlling the pressure within the autoclave vessel while heating the autoclave vessel to maintain a pressure within ±10% of the initial pressure via a second valve; and cooling the autoclave vessel after sterilization.
-
3.
公开(公告)号:US09669151B2
公开(公告)日:2017-06-06
申请号:US14642538
申请日:2015-03-09
发明人: Carol A. Rae , Jan Simoni , Grace Simoni , John F. Moeller
IPC分类号: A61M1/36
CPC分类号: A61M1/3679 , A61M5/165 , A61M2202/0021 , A61M2202/0042 , A61M2202/0413 , A61M2202/206 , B01J20/20 , B01J47/02
摘要: A method comprising obtaining a bodily fluid from a subject; contacting the bodily fluid with an adsorbent material comprising a synthetic carbon particle (SCP) to produce a first filtrate having a level of disease mediators (y); contacting the first filtrate with an adsorbent material comprising the SCP and an anion exchange resin where the ratio of SCP to anion exchange resin is from about 0.1:100 to 100:0.1 to produce a second filtrate; contacting the second filtrate with an adsorbent material comprising the SCP and a cation exchange resin where the ratio of SCP to cation exchange resin is from about 1:100 to produce a third filtrate; and administering the third filtrate to the subject.
-
4.
公开(公告)号:US20230372596A1
公开(公告)日:2023-11-23
申请号:US18230040
申请日:2023-08-03
发明人: Carol A. Rae , Jan Simoni , Grace Simoni , John F. Moeller
CPC分类号: A61M1/3679 , B01J20/20 , B01J47/02 , A61M2202/206 , A61M5/165
摘要: A method comprising obtaining a bodily fluid from a subject; contacting the bodily fluid with an adsorbent material comprising a synthetic carbon particle (SCP) to produce a first filtrate having a level of disease mediators (y); contacting the first filtrate with an adsorbent material comprising the SCP and an anion exchange resin where the ratio of SCP to anion exchange resin is in a range from about 0.1:100 to 100:0.1 to produce a second filtrate; contacting the second filtrate with an adsorbent material comprising the SCP and a cation exchange resin where the ratio of SCP to cation exchange resin is in a range from about 0.1:100 to 100:0.1 to produce a third filtrate.
-
公开(公告)号:US11253794B2
公开(公告)日:2022-02-22
申请号:US15545233
申请日:2016-05-27
发明人: Carol A. Rae , Jan S. Simoni , John F. Moeller
IPC分类号: B01D15/20 , B01D15/38 , B01J20/04 , B01J20/28 , A61K35/14 , B01D15/34 , B01J20/20 , A61K35/00
摘要: A method of preparing a universal blood product comprising obtaining a blood product; contacting the blood product with (i) hydroxyapatite; (ii) a carbonaceous material comprising at least a mixture of a first carbon particle having macroporous size α and a second carbon particle having macroporous size β; and (iii) at least one support matrix chemically associated with an antigenic determinant. to form a cleansed product; and recovering the cleansed product. A method of preparing a universal blood product comprising obtaining a blood product; contacting the blood product with (i) hydroxyapatite; (ii) a carbonaceous material comprising at least a mixture of a first carbon particle having macroporous size α and a second carbon particle having macroporous size β; and (iii) at least one support matrix chemically associated with an antigenic determinant. to form a cleansed product; wherein at least one of the hydroxyapatite, carbonaceous material and support matrix is functionalized.
-
公开(公告)号:US10960022B2
公开(公告)日:2021-03-30
申请号:US16161546
申请日:2018-10-16
发明人: Carol A Rae , Jan Simoni , Grace Simoni , John F. Moeller
IPC分类号: A61K33/44 , A61M1/36 , B01J47/026 , A61K9/14
摘要: A three component composition for use in the treatment of an autoimmune disease where the first component comprises a bimodal synthetic carbon particle mixture; the second component comprises a bimodal synthetic carbon particle mixture and an anion exchange resin and the third component comprises a bimodal synthetic carbon particle mixture and a cation exchange resin.
-
7.
公开(公告)号:US20170304524A1
公开(公告)日:2017-10-26
申请号:US15513221
申请日:2015-11-18
发明人: Carol A. Rae , Jan Simoni , Grace Simoni , John F. Moeller
CPC分类号: A61M1/3679 , A61M1/0281 , A61M1/14 , A61M1/3687 , B01J20/20 , B01J47/02
摘要: A method comprising obtaining a bodily fluid from a subject; contacting the bodily fluid with an adsorbent material comprising a synthetic carbon particle (SCP) to produce a first filtrate having a level of disease mediators (y); contacting the first filtrate with an adsorbent material comprising the SCP and an anion exchange resin where the ratio of SCP to anion exchange resin is from about 0.1:100 to 100:0.1 to produce a second filtrate; contacting the second filtrate with an adsorbent material comprising the SCP and a cation exchange resin where the ratio of SCP to cation exchange resin is from about 1:100 to produce a third filtrate; and administering the third filtrate to the subject.
-
8.
公开(公告)号:US11896753B2
公开(公告)日:2024-02-13
申请号:US16807858
申请日:2020-03-03
发明人: Carol A. Rae , Jan Simoni , Grace Simoni , John F. Moeller
CPC分类号: A61M1/3679 , A61M1/0281 , A61M1/14 , A61M1/3687 , B01J20/20 , B01J47/02
摘要: A method comprising obtaining a bodily fluid from a subject; contacting the bodily fluid with an adsorbent material comprising a synthetic carbon particle (SCP) to produce a first filtrate having a level of disease mediators (y); contacting the first filtrate with an adsorbent material comprising the SCP and an anion exchange resin where the ratio of SCP to anion exchange resin is from about 0.1:100 to 100:0.1 to produce a second filtrate; contacting the second filtrate with an adsorbent material comprising the SCP and a cation exchange resin where the ratio of SCP to cation exchange resin is from about 1:100 to produce a third filtrate; and administering the third filtrate to the subject.
-
公开(公告)号:US11839628B2
公开(公告)日:2023-12-12
申请号:US17213561
申请日:2021-03-26
发明人: Carol A Rae , Jan Simoni , Grace Simoni , John F. Moeller
IPC分类号: A61K33/44 , A61M1/36 , B01J47/026 , A61K9/14
CPC分类号: A61K33/44 , A61K9/14 , A61M1/3679 , B01J47/026
摘要: A three component composition for use in the treatment of an autoimmune disease where the first component comprises a bimodal synthetic carbon particle mixture; the second component comprises a bimodal synthetic carbon particle mixture and an anion exchange resin and the third component comprises a bimodal synthetic carbon particle mixture and a cation exchange resin.
-
10.
公开(公告)号:US11759561B2
公开(公告)日:2023-09-19
申请号:US17008783
申请日:2020-09-01
发明人: Carol A. Rae , Jan Simoni , Grace Simoni , John F. Moeller
CPC分类号: A61M1/3679 , B01J20/20 , B01J47/02 , A61M5/165 , A61M2202/0021 , A61M2202/0042 , A61M2202/0413 , A61M2202/206
摘要: A method comprising obtaining a bodily fluid from a subject; contacting the bodily fluid with an adsorbent material comprising a synthetic carbon particle (SCP) to produce a first filtrate having a level of disease mediators (y); contacting the first filtrate with an adsorbent material comprising the SCP and an anion exchange resin where the ratio of SCP to anion exchange resin is from about 0.1:100 to 100:0.1 to produce a second filtrate; contacting the second filtrate with an adsorbent material comprising the SCP and a cation exchange resin where the ratio of SCP to cation exchange resin is from about 1:100 to produce a third filtrate; and administering the third filtrate to the subject.
-
-
-
-
-
-
-
-
-